Request for Covid-19 Impact Assessment of this Report
Scope of the Report:
This report focuses on the Neurological Biomarkers in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.
Market Segment by Manufacturers, this report covers
Thermo Fisher
Merck
Bio-Rad Laboratories
Roche
QIAGEN
Athena Diagnostics
Myriad RBM
Cisbio Bioassays
Wuxi APP
BGI
Aepodia
Genewiz
Proteome Sciences
Market Segment by Countries, covering
United States
Canada
Mexico
Market Segment by Type, covers
Proteomics
Genomics
Imaging
Bioinformatics
Others
Market Segment by Applications, can be divided into
Diagnostics
Drug Discovery
Personalized Medicine
Others
There are 15 Chapters to deeply display the North America Neurological Biomarkers market.
Chapter 1, to describe Neurological Biomarkers Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;
Chapter 2, to analyze the manufacturers of Neurological Biomarkers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Neurological Biomarkers, for each country, from 2012 to 2017;
Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;
Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;
Chapter 10, Neurological Biomarkers market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;
Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.
Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);
Chapter 13, to describe sales channel, distributors, traders, dealers etc.
Chapter 14 and 15, to describe Neurological Biomarkers Research Findings and Conclusion, Appendix, methodology and data source
1 Market Overview
1.1 Neurological Biomarkers Introduction
1.2 Market Analysis by Type
1.2.1 Proteomics
1.2.2 Genomics
1.2.3 Imaging
1.2.4 Bioinformatics
1.2.5 Others
1.3 Market Analysis by Applications
1.3.1 Diagnostics
1.3.2 Drug Discovery
1.3.3 Personalized Medicine
1.3.4 Others
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 Mexico Status and Prospect (2012-2022)
1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Thermo Fisher
2.1.1 Profile
2.1.2 Neurological Biomarkers Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Thermo Fisher Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 Thermo Fisher News
2.2 Merck
2.2.1 Profile
2.2.2 Neurological Biomarkers Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Merck Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 Merck News
2.3 Bio-Rad Laboratories
2.3.1 Profile
2.3.2 Neurological Biomarkers Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Bio-Rad Laboratories Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 Bio-Rad Laboratories News
2.4 Roche
2.4.1 Profile
2.4.2 Neurological Biomarkers Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Roche Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 Roche News
2.5 QIAGEN
2.5.1 Profile
2.5.2 Neurological Biomarkers Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 QIAGEN Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 QIAGEN News
2.6 Athena Diagnostics
2.6.1 Profile
2.6.2 Neurological Biomarkers Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Athena Diagnostics Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.4 Business Overview
2.6.5 Athena Diagnostics News
2.7 Myriad RBM
2.7.1 Profile
2.7.2 Neurological Biomarkers Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Myriad RBM Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.4 Business Overview
2.7.5 Myriad RBM News
2.8 Cisbio Bioassays
2.8.1 Profile
2.8.2 Neurological Biomarkers Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Cisbio Bioassays Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.4 Business Overview
2.8.5 Cisbio Bioassays News
2.9 Wuxi APP
2.9.1 Profile
2.9.2 Neurological Biomarkers Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Wuxi APP Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.4 Business Overview
2.9.5 Wuxi APP News
2.10 BGI
2.10.1 Profile
2.10.2 Neurological Biomarkers Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 BGI Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.4 Business Overview
2.10.5 BGI News
2.11 Aepodia
2.11.1 Profile
2.11.2 Neurological Biomarkers Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Aepodia Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11.4 Business Overview
2.11.5 Aepodia News
2.12 Genewiz
2.12.1 Profile
2.12.2 Neurological Biomarkers Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Genewiz Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12.4 Business Overview
2.12.5 Genewiz News
2.13 Proteome Sciences
2.13.1 Profile
2.13.2 Neurological Biomarkers Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 Proteome Sciences Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13.4 Business Overview
2.13.5 Proteome Sciences News
3 North America Neurological Biomarkers Market Competition, by Manufacturer
3.1 North America Neurological Biomarkers Sales and Market Share by Manufacturer (2016-2017)
3.2 North America Neurological Biomarkers Revenue and Market Share by Manufacturer (2016-2017)
3.3 North America Neurological Biomarkers Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Neurological Biomarkers Manufacturer Market Share
3.4.2 Top 5 Neurological Biomarkers Manufacturer Market Share
3.5 Market Competition Trend
4 North America Neurological Biomarkers Market Analysis by Countries
4.1 North America Neurological Biomarkers Sales Market Share by Countries
4.2 North America Neurological Biomarkers Sales by Countries (2012-2017)
4.3 North America Neurological Biomarkers Revenue (Value) by Countries (2012-2017)
5 North America Market Segmentation Neurological Biomarkers by Type
5.1 North America Neurological Biomarkers Sales, Revenue and Market Share by Type (2012-2017)
5.1.1 North America Neurological Biomarkers Sales and Market Share by Type (2012-2017)
5.1.2 North America Neurological Biomarkers Revenue and Market Share by Type (2012-2017)
5.2 Proteomics Sales Growth and Price
5.2.1 North America Proteomics Sales Growth (2012-2017)
5.2.2 North America Proteomics Price (2012-2017)
5.3 Genomics Sales Growth and Price
5.3.1 North America Genomics Sales Growth (2012-2017)
5.3.2 North America Genomics Price (2012-2017)
5.4 Imaging Sales Growth and Price
5.4.1 North America Imaging Sales Growth (2012-2017)
5.4.2 North America Imaging Price (2012-2017)
5.5 Bioinformatics Sales Growth and Price
5.5.1 North America Bioinformatics Sales Growth (2012-2017)
5.5.2 North America Bioinformatics Price (2012-2017)
5.6 Others Sales Growth and Price
5.6.1 North America Others Sales Growth (2012-2017)
5.6.2 North America Others Price (2012-2017)
6 North America Market Segmentation Neurological Biomarkers by Application
6.1 North America Neurological Biomarkers Sales Market Share by Application (2012-2017)
6.2 Diagnostics Sales Growth (2012-2017)
6.3 Drug Discovery Sales Growth (2012-2017)
6.4 Personalized Medicine Sales Growth (2012-2017)
6.5 Others Sales Growth (2012-2017)
7 United States Neurological Biomarkers Sales, Revenue, by Type, Application and Manufacturers
7.1 United States Neurological Biomarkers Revenue, Sales and Growth Rate (2012-2017)
7.2 United States Neurological Biomarkers Sales and Market Share by Type
7.3 United States Neurological Biomarkers Sales by Application (2012-2017)
7.4 United States Neurological Biomarkers Sales, Revenue and Market Share by Manufacturer
7.4.1 United States Neurological Biomarkers Sales and Market Share by Manufacturer
7.4.2 United States Neurological Biomarkers Revenue and Market Share by Manufacturer
7.5 United States Neurological Biomarkers Export and Import (2012-2017)
8 Canada Neurological Biomarkers Sales, Revenue, by Type, Application and Manufacturers
8.1 Canada Neurological Biomarkers Revenue, Sales and Growth Rate (2012-2017)
8.2 Canada Neurological Biomarkers Sales and Market Share by Type
8.3 Canada Neurological Biomarkers Sales by Application (2012-2017)
8.4 Canada Neurological Biomarkers Sales, Revenue and Market Share by Manufacturer
8.4.1 Canada Neurological Biomarkers Sales and Market Share by Manufacturer
8.4.2 Canada Neurological Biomarkers Revenue and Market Share by Manufacturer
8.5 Canada Neurological Biomarkers Export and Import (2012-2017)
9 Mexico Neurological Biomarkers Sales, Revenue, by Type, Application and Manufacturers
9.1 Mexico Neurological Biomarkers Revenue, Sales and Growth Rate (2012-2017)
9.2 Mexico Neurological Biomarkers Sales and Market Share by Type
9.3 Mexico Neurological Biomarkers Sales by Application (2012-2017)
9.4 Mexico Neurological Biomarkers Sales, Revenue and Market Share by Manufacturer
9.4.1 Mexico Neurological Biomarkers Sales and Market Share by Manufacturer
9.4.2 Mexico Neurological Biomarkers Revenue and Market Share by Manufacturer
9.5 Mexico Neurological Biomarkers Export and Import (2012-2017)
10 Neurological Biomarkers Market Forecast (2017-2022)
10.1 North America Neurological Biomarkers Sales, Revenue and Growth Rate (2017-2022)
10.2 Neurological Biomarkers Market Forecast by Countries (2017-2022)
10.2.1 United States Neurological Biomarkers Forecast (2017-2022)
10.2.2 Canada Neurological Biomarkers Forecast (2017-2022)
10.2.3 Mexico Neurological Biomarkers Forecast (2017-2022)
10.3 Neurological Biomarkers Market Forecast by Type (2017-2022)
10.4 Neurological Biomarkers Market Forecast by Application (2017-2022)
11 Neurological Biomarkers Manufacturing Cost Analysis
11.1 Neurological Biomarkers Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Neurological Biomarkers
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Neurological Biomarkers Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Neurological Biomarkers Major Manufacturers in 2016
12.4 Downstream Buyers
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source
Figure Neurological Biomarkers Picture
Table Product Specifications of Neurological Biomarkers
Figure North America Sales Market Share of Neurological Biomarkers by Types in 2016
Table Types of Neurological Biomarkers
Figure Proteomics Picture
Table Major Manufacturers of Proteomics
Figure Genomics Picture
Table Major Manufacturers of Genomics
Figure Imaging Picture
Table Major Manufacturers of Imaging
Figure Bioinformatics Picture
Table Major Manufacturers of Bioinformatics
Figure Others Picture
Table Major Manufacturers of Others
Table North America Neurological Biomarkers Sales Market Share by Applications in 2016
Table Applications of Neurological Biomarkers
Figure Diagnostics Picture
Figure Drug Discovery Picture
Figure Personalized Medicine Picture
Figure Others Picture
Figure United States Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure Mexico Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure Canada Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Table Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table Thermo Fisher Neurological Biomarkers Type and Applications
Table Thermo Fisher Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Neurological Biomarkers Type and Applications
Table Merck Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table Bio-Rad Laboratories Neurological Biomarkers Type and Applications
Table Bio-Rad Laboratories Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Neurological Biomarkers Type and Applications
Table Roche Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table QIAGEN Basic Information, Manufacturing Base and Competitors
Table QIAGEN Neurological Biomarkers Type and Applications
Table QIAGEN Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Athena Diagnostics Basic Information, Manufacturing Base and Competitors
Table Athena Diagnostics Neurological Biomarkers Type and Applications
Table Athena Diagnostics Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Myriad RBM Basic Information, Manufacturing Base and Competitors
Table Myriad RBM Neurological Biomarkers Type and Applications
Table Myriad RBM Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Cisbio Bioassays Basic Information, Manufacturing Base and Competitors
Table Cisbio Bioassays Neurological Biomarkers Type and Applications
Table Cisbio Bioassays Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Wuxi APP Basic Information, Manufacturing Base and Competitors
Table Wuxi APP Neurological Biomarkers Type and Applications
Table Wuxi APP Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table BGI Basic Information, Manufacturing Base and Competitors
Table BGI Neurological Biomarkers Type and Applications
Table BGI Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Aepodia Basic Information, Manufacturing Base and Competitors
Table Aepodia Neurological Biomarkers Type and Applications
Table Aepodia Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Genewiz Basic Information, Manufacturing Base and Competitors
Table Genewiz Neurological Biomarkers Type and Applications
Table Genewiz Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Proteome Sciences Basic Information, Manufacturing Base and Competitors
Table Proteome Sciences Neurological Biomarkers Type and Applications
Table Proteome Sciences Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table North America Neurological Biomarkers Sales by Manufacturer (2016-2017)
Figure North America Neurological Biomarkers Sales Market Share by Manufacturer in 2016
Figure North America Neurological Biomarkers Sales Market Share by Manufacturer in 2017
Table North America Neurological Biomarkers Revenue by Manufacturer (2016-2017)
Figure North America Neurological Biomarkers Revenue Market Share by Manufacturer in 2016
Figure North America Neurological Biomarkers Revenue Market Share by Manufacturer in 2017
Table North America Neurological Biomarkers Price by Manufacturers (2016-2017)
Figure Top 3 Neurological Biomarkers Manufacturer Market Share in 2016
Figure Top 3 Neurological Biomarkers Manufacturer Market Share in 2017
Figure Top 5 Neurological Biomarkers Manufacturer Market Share in 2016
Figure Top 5 Neurological Biomarkers Manufacturer Market Share in 2017
Figure North America Neurological Biomarkers Sales and Growth (2012-2017)
Table North America Neurological Biomarkers Sales by Countries (2012-2017)
Table North America Neurological Biomarkers Sales Market Share by Countries (2012-2017)
Figure North America 2012 Neurological Biomarkers Sales Market Share by Countries
Figure North America 2016 Neurological Biomarkers Sales Market Share by Countries
Figure North America Neurological Biomarkers Revenue and Growth (2012-2017)
Table North America Neurological Biomarkers Revenue by Countries (2012-2017)
Table North America Neurological Biomarkers Revenue Market Share by Countries (2012-2017)
Table North America 2012 Neurological Biomarkers Revenue Market Share by Countries
Table North America 2016 Neurological Biomarkers Revenue Market Share by Countries
Table North America Neurological Biomarkers Sales by Type (2012-2017)
Table North America Neurological Biomarkers Sales Share by Type (2012-2017)
Table North America Neurological Biomarkers Revenue by Type (2012-2017)
Table North America Neurological Biomarkers Revenue Share by Type (2012-2017)
Figure North America Proteomics Sales Growth (2012-2017)
Figure North America Proteomics Price (2012-2017)
Figure North America Genomics Sales Growth (2012-2017)
Figure North America Genomics Price (2012-2017)
Figure North America Imaging Sales Growth (2012-2017)
Figure North America Imaging Price (2012-2017)
Figure North America Bioinformatics Sales Growth (2012-2017)
Figure North America Bioinformatics Price (2012-2017)
Figure North America Others Sales Growth (2012-2017)
Figure North America Others Price (2012-2017)
Table North America Neurological Biomarkers Sales by Application (2012-2017)
Table North America Neurological Biomarkers Sales Share by Application (2012-2017)
Figure North America Diagnostics Sales Growth (2012-2017)
Figure North America Drug Discovery Sales Growth (2012-2017)
Figure North America Personalized Medicine Sales Growth (2012-2017)
Figure North America Others Sales Growth (2012-2017)
Figure United States Neurological Biomarkers Revenue and Growth (2012-2017)
Figure United States Neurological Biomarkers Sales and Growth (2012-2017)
Table United States Neurological Biomarkers Sales by Type (2012-2017)
Table United States Neurological Biomarkers Sales Market Share by Type (2012-2017)
Table United States Neurological Biomarkers Sales by Application (2012-2017)
Table United States Neurological Biomarkers Sales Market Share by Application (2012-2017)
Table United States Neurological Biomarkers Sales by Manufacturer (2016-2017)
Figure United States Neurological Biomarkers Sales Market Share by Manufacturer in 2016
Figure United States Neurological Biomarkers Sales Market Share by Manufacturer in 2017
Table United States Neurological Biomarkers Revenue by Manufacturer (2016-2017)
Figure United States Neurological Biomarkers Revenue Market Share by Manufacturer in 2016
Figure United States Neurological Biomarkers Revenue Market Share by Manufacturer in 2017
Table United States Neurological Biomarkers Export and Import (2012-2017)
Figure Canada Neurological Biomarkers Revenue and Growth (2012-2017)
Figure Canada Neurological Biomarkers Sales and Growth (2012-2017)
Table Canada Neurological Biomarkers Sales by Type (2012-2017)
Table Canada Neurological Biomarkers Sales Market Share by Type (2012-2017)
Table Canada Neurological Biomarkers Sales by Application (2012-2017)
Table Canada Neurological Biomarkers Sales Market Share by Application (2012-2017)
Table Canada Neurological Biomarkers Sales by Manufacturer (2016-2017)
Figure Canada Neurological Biomarkers Sales Market Share by Manufacturer in 2016
Figure Canada Neurological Biomarkers Sales Market Share by Manufacturer in 2017
Table Canada Neurological Biomarkers Revenue by Manufacturer (2016-2017)
Figure Canada Neurological Biomarkers Revenue Market Share by Manufacturer in 2016
Figure Canada Neurological Biomarkers Revenue Market Share by Manufacturer in 2017
Table Canada Neurological Biomarkers Export and Import (2012-2017)
Figure Mexico Neurological Biomarkers Revenue and Growth (2012-2017)
Figure Mexico Neurological Biomarkers Sales and Growth (2012-2017)
Table Mexico Neurological Biomarkers Sales by Type (2012-2017)
Table Mexico Neurological Biomarkers Sales Market Share by Type (2012-2017)
Table Mexico Neurological Biomarkers Sales by Application (2012-2017)
Table Mexico Neurological Biomarkers Sales Market Share by Application (2012-2017)
Table Mexico Neurological Biomarkers Sales by Manufacturer (2016-2017)
Figure Mexico Neurological Biomarkers Sales Market Share by Manufacturer in 2016
Figure Mexico Neurological Biomarkers Sales Market Share by Manufacturer in 2017
Table Mexico Neurological Biomarkers Revenue by Manufacturer (2016-2017)
Figure Mexico Neurological Biomarkers Revenue Market Share by Manufacturer in 2016
Figure Mexico Neurological Biomarkers Revenue Market Share by Manufacturer in 2017
Table Mexico Neurological Biomarkers Export and Import (2012-2017)
Figure North America Neurological Biomarkers Sales, Revenue and Growth Rate (2017-2022)
Table North America Neurological Biomarkers Sales Forecast by Countries (2017-2022)
Table North America Neurological Biomarkers Market Share Forecast by Countries (2017-2022)
Figure United States Neurological Biomarkers Sales Forecast (2017-2022)
Figure Canada Neurological Biomarkers Sales Forecast (2017-2022)
Figure Mexico Neurological Biomarkers Sales Forecast (2017-2022)
Table North America Neurological Biomarkers Sales Forecast by Type (2017-2022)
Table North America Neurological Biomarkers Market Share Forecast by Type (2017-2022)
Table North America Neurological Biomarkers Sales Forecast by Application (2017-2022)
Table North America Neurological Biomarkers Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neurological Biomarkers
Figure Manufacturing Process Analysis of Neurological Biomarkers
Figure Neurological Biomarkers Industrial Chain Analysis
Table Raw Materials Sources of Neurological Biomarkers Major Manufacturers in 2016
Table Major Buyers of Neurological Biomarkers
Table Distributors/Traders/ Dealers List
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...